Michiel S van der Heijden Selected Research

Michiel S van der Heijden Research Topics

Disease

45	Neoplasms (Cancer) 03/2024 - 06/2002
29	Urinary Bladder Neoplasms (Bladder Cancer) 01/2024 - 08/2015
28	Carcinoma (Carcinomatosis) 03/2024 - 07/2014
6	Neoplasm Metastasis (Metastasis) 05/2023 - 07/2014
4	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 11/2019
3	Disease Progression 03/2024 - 11/2017
3	Pancreatic Neoplasms (Pancreatic Cancer) 11/2018 - 06/2002
2	Penile Neoplasms (Penile Cancer) 11/2023 - 09/2019
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 11/2023 - 01/2020
2	Breast Neoplasms (Breast Cancer) 01/2023 - 11/2016
2	Neutropenia 12/2020 - 01/2020
2	Pneumonia (Pneumonitis) 12/2020 - 05/2016
2	Microsatellite Instability 10/2018 - 01/2006
2	Lung Neoplasms (Lung Cancer) 01/2017 - 06/2002
2	Fanconi Anemia (Fanconi's Anemia) 10/2005 - 05/2003
2	Hypersensitivity (Allergy) 08/2004 - 05/2003
1	Body Weight (Weight, Body) 03/2024
1	Urologic Neoplasms (Urological Cancer) 02/2024
1	Pain (Aches) 02/2024
1	Tertiary Lymphoid Structures 01/2021
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2021
1	Pyelonephritis 01/2021
1	Urinary Tract Infections (Urinary Tract Infection) 01/2021
1	Acute Kidney Injury (Acute Renal Failure) 12/2020
1	Acute Liver Failure (Fulminant Hepatic Failure) 12/2020
1	Hepatitis 12/2020
1	Septic Shock (Toxic Shock Syndrome) 12/2020
1	Drug-Related Side Effects and Adverse Reactions 12/2020
1	Inflammation (Inflammations) 01/2020
1	Febrile Neutropenia 01/2020
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2020
1	Urachal adenocarcinoma 09/2019
1	Urachal cancer 09/2019

Drug/Important Bio-Agent (IBA)

17	Cisplatin (Platino)FDA LinkGeneric 03/2024 - 10/2005
16	PlatinumIBA 03/2024 - 03/2016
12	atezolizumabIBA 11/2023 - 05/2016
11	Immune Checkpoint InhibitorsIBA 03/2024 - 05/2016
8	Biomarkers (Surrogate Marker)IBA 06/2023 - 05/2016
6	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2006
5	Gemcitabine FDA Link 03/2024 - 10/2005
5	NivolumabIBA 11/2023 - 12/2020
4	IpilimumabIBA 07/2023 - 12/2020
4	RamucirumabIBA 01/2022 - 11/2017
4	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 05/2003
4	Docetaxel (Taxotere)FDA Link 01/2021 - 11/2017
4	Mitomycin (Mitomycin-C)FDA LinkGeneric 01/2020 - 05/2003
3	enfortumab vedotinIBA 03/2024 - 01/2021
3	TOR Serine-Threonine KinasesIBA 07/2022 - 06/2010
3	Paclitaxel (Taxol)FDA LinkGeneric 01/2021 - 10/2005
3	Fluorouracil (Carac)FDA LinkGeneric 01/2020 - 10/2005
3	Phenobarbital (Luminal)FDA Link 01/2020 - 10/2017
2	Carboplatin (JM8)FDA LinkGeneric 03/2024 - 01/2022
2	Immunoconjugates (Immunoconjugate)IBA 01/2023 - 01/2021
2	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 01/2023 - 01/2017
2	Sirolimus (Rapamycin)FDA Link 07/2022 - 01/2018
2	RNA (Ribonucleic Acid)IBA 01/2022 - 02/2009
2	Interleukin-8 (Interleukin 8)IBA 03/2021 - 01/2020
2	Androgen Receptors (Androgen Receptor)IBA 01/2021 - 12/2019
2	vinflunineIBA 01/2021 - 01/2018
2	enzalutamideIBA 01/2021 - 12/2019
2	durvalumabIBA 12/2020 - 12/2020
2	tremelimumabIBA 12/2020 - 12/2020
2	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 01/2020 - 11/2017
2	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2017 - 06/2010
2	Phosphotransferases (Kinase)IBA 11/2016 - 05/2004
1	pembrolizumabIBA 03/2024
1	Messenger RNA (mRNA)IBA 01/2023
1	Ado-Trastuzumab EmtansineIBA 01/2023
1	RogaratinibIBA 01/2023
1	human ERBB2 proteinIBA 01/2023
1	Monoclonal AntibodiesIBA 01/2022
1	Biocompatible Materials (Biomaterials)IBA 01/2021
1	Lipase (Acid Lipase)FDA Link 12/2020
1	Circulating Tumor DNAIBA 12/2020
1	Type 3 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 3)IBA 11/2020
1	Immunoglobulin G (IgG)IBA 01/2020
1	TabletsIBA 01/2020
1	AndrogensIBA 01/2020
1	Hormones (Hormone)IBA 01/2020
1	Capecitabine (Xeloda)FDA Link 01/2020
1	Co-Repressor ProteinsIBA 12/2019
1	apalutamideIBA 12/2019
1	Long Noncoding RNAIBA 10/2019
1	SolutionsIBA 10/2019
1	Panitumumab (Vectibix)FDA Link 01/2019

Therapy/Procedure

24	Drug Therapy (Chemotherapy) 03/2024 - 05/2016
20	Therapeutics 01/2024 - 10/2005
17	Cystectomy 01/2024 - 07/2014
11	Neoadjuvant Therapy 12/2023 - 07/2014
8	Immunotherapy 12/2022 - 01/2019
4	Lymph Node Excision (Lymph Node Dissection) 01/2021 - 02/2016
2	Radiotherapy 11/2023 - 01/2019
2	Adjuvant Radiotherapy 05/2023 - 01/2020
2	Induction Chemotherapy 01/2019 - 12/2016
1	Precision Medicine 12/2023
1	Nephroureterectomy 01/2021
1	Aftercare (After-Treatment) 01/2021
1	Castration 11/2019
1	Cytoreduction Surgical Procedures 09/2019
1	Hyperthermic Intraperitoneal Chemotherapy 09/2019